U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07035041) titled 'A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis' on May 19.
Brief Summary: This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with moderately to severely active ulcerative colitis. A total of 120 subjects are planned to be included.
Study Start Date: May 22
Study Type: INTERVENTIONAL
Condition:
UC - Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Intervention:
DRUG: D-2570
Subjects will then be randomized in a 1:1:1 ratio to D-2570 or placebo . They will enter the study treatment period and ...